Karbinal Suspension, Extended Release
Product Images NDC 23594-101

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Karbinal (NDC 23594-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aytu Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aytu Biopharma Logo

FDA Label Image

Chemical Structure (Karbinal 01)

Chemical structure diagram of Carbinoxamine Maleate, the active ingredient in Karbinal ER 4 mg/5mL extended-release oral suspension by Aytu Therapeutics, LLC.*

FDA Label Image

Chemical Structure (Karbinal 02)

Chemical structure diagram showing a polymer molecule containing sodium sulfonate groups (SO3Na) and benzene rings bonded to a hydrocarbon backbone. The structure indicates a repeating unit in the polymer chain, with hydrogen atoms attached at various positions.*

FDA Label Image

Karbinal 16oz

Label for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension, 4 mg/5 mL strength. The label includes dosage form, flavor (strawberry banana), usage instructions (shake well, dose every 12 hours), container volume of 16 fl oz (480 mL), manufacturer Tris Pharma, Inc., and distributor Aytu Therapeutics, LLC. The label also features storage instructions, a barcode, and the LiquiXR technology logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.